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1 INTRODUCTION 
Information systems (IS) are not only concerned with the application of modern technology to assist 
with medical services, but also to reduce medical errors and improve the quality of patient care. 
Accordingly, Electronic Health Record systems (EHRs) play an important role in modern clinical 
service based on the development of information technology. Awareness of EHRs success is 
important, as that would assist in providing suitable EHRs for satisfying the requirements of clinical 
service. It is because EHRs not only help the management of administration and finances for 
improving work efficiency in clinical services, but also help to reduce human errors in patient care. 
Promoting EHRs have been a national goal in Taiwan, therefore, it is essential to (1) understand 
end-user’ opinion for identifying whether EHRs success would help to recognize the strengths and 
weaknesses of such systems; (2) provide useful suggestions to improve the functions of EHRs for 
patient care; (3) realize the impact of using such systems in clinical service. Moreover, with proper 
success assessment, it offers evidence-based information for health care executives and EHRs 
developers, the importance of providing a suitable user-centred EHR system for patient care. This will 
lead to safer and acceptable EHRs. As a result, it needs an appropriate evaluation instrument to assess 
above aims. 
The Declaration of Innsbruck suggested that Evaluation studies should be grounded on scientific 
theory and conduct with rigorous approaches (Ammenwerth, Brender et al. 2004). This research 
applies the issue of “Socio-Technical theory” (Bostrom & Heinen 1977) and “User-centred 
perspective” (Hesse & Shneiderman 2007) to establish a conceptual evaluation framework and design 
an appropriate instrument for evaluating Taiwanese EHRs. In order to recognize the most appropriate 
factor/attributes in evaluating EHRs, this study applies the strategy of “Triangulation research 
method” in health information systems research, by triangulation of investigator and method. This 
article validates the appropriate evaluation framework applicable for EHRs by applying the strategy of 
modified Delphi method (Snyder-Halpern 2001), which could be regarded as a reference for 
supporting investment decisions in health care. In addition, it also presented the results of content 
validation (Polit & Beck 2006) by calculating content validity index (CVI) for items (I-CVI) (Polit & 
Beck 2006) and content validity index for scales (S-CVI) (Hubley & Palepu 2007) to validate the 
proposed evaluation framework and construct an appropriate questionnaire for the evaluation of 
Taiwanese EHRs.   
2 BACKGROUND AND CONCEPTUAL EVALUATION FRAMEWORK 
A comprehensive framework for evaluating Taiwanese EHRs success needs to consider the features 
of the Taiwanese healthcare delivery system (a centralized medical system) and related regulations, 
such as the Medical Act, the National Health Insurance (NHI) and the Taiwanese Hospital 
Accreditation Program. In other words, the operational strategies of healthcare administration are 
affected by the outer healthcare environment in Taiwan, such as health policies and national health 
insurance. Secondly, a user-centred evaluation framework needs to cover various aspects, therefore, 
with regard to the knowledge of Evidence-based Health Care Management (Wan 2002), the issue of 
Social-technical theory (Bostrom & Heinen 1977), the issue of Structure-Process-Outcome (S-P-O) 
model (Donabedian 2003) and the meaning of Health Information System (HIS) evaluation 
(Ammenwerth, Graber et al. 2003), it needs to understand the relationships between the technology 
itself and its users for implementing EHRs based on end-users’ opinion of using such systems.  
In order to satisfy above requirements and combining the knowledge of aforementioned issues, this 
study proposed that structure covers aspects of organizational and technology; process equates to 
human aspects; outcomes are related to net benefits. In addition, the DeLone and McLean IS success 
model (DeLone & McLean 1992) had been combined with the S-P-O model, however, it still needs 
empirical research to identify whether the updated D&M IS success model could be combined with 
the S-P-O model and a Social-technical approach in EHR systems evaluation. Moreover, a patient is 
regarded as an outer customer and a healthcare professional as an inner customer within the issue of 
organizational behaviour. In order to improve the quality of patient care for outer customers, it is 
essential for health care executives to firstly improve the work satisfaction of its inner customers. 
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Accordingly, Organizational aspects need to concern about Healthcare environment (External 
organization) and Organizational Behaviours (Internal organization). In addition, EHRs include 
patients’ health information, any error or inaccuracy can have impact on patient care; regarding 
clinical data of EHR and the development of both intranet and internet in hospitals, therefore, clinical 
data quality (D’Onofrio & Gendron 2001) and safety quality (Win 2004; Su, Win et al. 2006) are also 
important for the EHRs. Furthermore, realizing an end-user’s attitude of using such systems will 
provides sufficient information for health care executives to access end-users’ opinion and to 
recognize that whether the net benefits of implementing EHR will affect the strategies of hospital 
management. In short, this study considers that the aspects of Environment cover the dimensions of 
Healthcare Environment (HE) and Organization Behaviours (OB); the aspects of Technology cover 
the dimensions of System Quality (Sys_Q), Medical Data Quality (MDQ), Service Quality (Ser_Q), 
and Safety Quality (Safe_Q); the aspects of Human cover the dimensions of User Usage (UU) and 
User Satisfaction (US); the aspects of Net Benefits covers the dimensions of Organization Net 
Benefits (ONB) (Table 1 and Figure 1).  
Aspects Elements Operational Definitions 
Healthcare 
Environment (HE) 
Realizing end-users’ impression of national health 
policies of EHRs. Organizational Organizational 
Behaviours (OB) 
Recognizing end-users’ impressions of the reasons and 
motivation to implement EHRs within a hospital. 
System Quality 
(Sys_Q) 
Identifying end-users’ opinions of the performance 
distinctiveness of the EHRs processing it provides. 
Medical Data Quality 
(MDQ) 
Identifying end-users’ opinions of the output information 
produced by the EHRs. 
Service Quality  
(Ser_Q) 
Considering how to provide accessible help to the stakeholders 
of the EHRs by the technological vender based on identifying 
end-users’ judgment. 
Technology 
Safety Quality  
(Safe_Q) 
Identifying end-users’ opinions of risk management within 
EHRs. 
User Use (UU) Measuring the use of the EHR based on end-users’ judgment. 
Human User Satisfaction (US) Measuring the users’ responses by using the output information of EHRs. 
Net Benefits Organizational Net Benefits (ONB) 
Realizing the impact and goodness of implementing EHRs in 
patient care performance based on identifying end-users’ 
judgment. 
Table 1.  Definitions of the conceptual user-centred evaluation framework 
Organizational Net
Benefits
Safety
Quality
System
Quality
Medical Data
Quality
Service
Quality
Technological
Healthcare
Environment
Organizational
Behaviours
Organizational
User
Usage
User
Satisfaction
Human
 
Figure 1.  Taiwanese EHRs conceptual evaluation framework 
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3 RESEARCH METHOD 
According to the features of the modified Delphi method, the process of such a technique is 
commonly being applied in identifying the content validity of an instrument (Takemura, Liu et al. 
2006; Rushton & Lindsay 2008). Accordingly, there are several main elements in the Delphi method 
in order to obtain the most consistent agreement on each question of a questionnaire from a group of 
specialists (Snyder-Halpern 2001; van Steenkiste, Jacobs et al. 2002; Daniel & White 2005): (1) 
anonymity: it is nameless in applying such a method between experts; (2) iteration: it needs to 
perform the Delphi method at least twice on the same question for experts to reconsider their 
responses until consensus is reached; (3) controlled feedback: all inappropriate questions are removed 
by calculating each content validity index for items (I-CVI) and the overall content validity index for 
scales (S-CVI) of a evaluation instrument (S-CVI is the Mean of I-CVI); (4) aggregation of group 
answers: converting individual viewpoint into group consensus by providing results of each round to 
participants of the Delphi group. In order to design a suitable evaluation instrument by applying the 
knowledge of triangulation research method: A. for method triangulation, (1) a quantitative approach 
indicates the degree of consensus between and within questions by calculating I-CVI and S-CVI to 
determinate which question need to be removed from the instrument; (2) a qualitative approach 
provides a reference to modify wording and/or syntaxes of those questions which could be kept from 
results of I-CVI and S-CVI. B. for investigator triangulation, thirty participants (including medical 
doctors, nurses, medical technicians, high level healthcare administrators, and the director of the 
department of information management) were recruited as participants in this Delphi group. Experts 
within the Delphi group were requested to answer each question in the three main components 
(Importance, Feasibility, and Confidence).  
In order to confirm the content validity or face validity, the prepared evaluation instrument (appendix 
1) consists of three main components: (1) Importance: the significance of each evaluation question in 
its evaluation element; (2) Feasibility: the practicality of each evaluation question in a real medical 
environment; (3) Confidence: to measure experts’ opinions of whether or not they trust that the 
results of each question could be used to evaluate end-user’s opinion of using EHRs. This study 
adopted a five-point Likeret scale (1=strongly disagree; 2=disagree; 3=somewhat disagree; 4=agree; 
5=strongly agree)as the answer format (Lynn 1986).  
Content validity: “concerns the degree to which a sample of items, taken together, constitutes an 
adequate operational definition of a construct” (Polit & Beck 2006). Therefore, a quantitative 
approach of the Delphi method could be used to identify the content validity by calculating I-CVI (the 
value of the I-CVI is the summation of agreement, 4: agree and 5: highly agree) divided by the total 
number of experts) to determinate which question need to be removed from the proposed instrument, 
and the content validity index for S-CVI (adopting the average proportion of items which were 
approved by the experts and calculating this as the average of the I-CVI values) to recognize the 
proportion of agreement within the instrument. The determinate criterion (cut-off point) of I-CVI is 
0.78 (78%) and 0.90 (90%) for the S-CVI/Ave (Polit & Beck 2006).  
The special intention of each round is: (1) Round I focuses on ranking the aforementioned three main 
components in each question, and requesting experts to provide their viewpoint of each question if 
possible; (2) Round II not only repeats the same process of Round I for experts to reconsider their 
response to each question, but also requests experts to modify the wording and syntax of each 
question to refine this prepared instrument. If the degree of consensus is stable among experts in 
Round II, this will complete the process of performing the Delphi method; otherwise, it will be 
repeated until all inappropriate questions are removed by calculating each I-CVI and the overall 
S-CVI of the proposed evaluation instrument.  
4 RESULTS 
It took around nine weeks (from 9th October to 11th December 2006) to collect data from the Delphi 
Group twice, due to the degree of consensus stability among experts in Round II. In Round I, 23 of 
30 experts (76.67%) responded to the questionnaire: 10 were medical doctors, 6 were executive 
nursing staff, 5 were executive healthcare administrators, and 2 were executive managers of 
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information management. In other words, the ratio of participants (clinical vs. non-clinical) was close 
to 2.3:1; sixteen were health professionals and the others were executive managers. In Round II, 19 
of 23 experts (82.60%) responded: 8 were medical doctors, 5 were executive nursing staff, 4 were 
executive healthcare administrators, and 2 were executive managers of information management. In 
other words, the ratio of participants (clinical vs. non-clinical) was close to 2.1:1; 13 were health 
professionals and the others were executive managers.  
Based on the results of the two-interactive Delphi methods, the results of I-CVI (Table 2) suggest that 
the following seven questions: HE2, OB2, OB4, UU4, UU5, US2 and US4-1 need to be removed 
from the proposed instrument. Taking HE2 for example, the original content of HE2 is “Do you 
know that all the hospitals around your hospital are implementing EHRs in their patient 
service”, in other words, several experts of the Delphi group suggested that such a question is 
not relevant (rated 1 or 2 and 3) to the underlying construct (Healthcare Environment). For 
OB4, the content of the question is “You agreed with the leadership and administration of top 
managers for adopting EHR within your hospital?” Experts suggested that such a question is 
inappropriate in this study due to its being a sensitive issue of organizational culture and 
end-users would not tell the truth. As a result, this could be used to explain why the values of 
I-CVI in such questions are lower than 78% in those three components (Importance, 
Feasibility and Confidence).  
In addition, five questions (HE3, HE4, UU2, UU3 and US3) need to be modified to be more relevant 
to its proposed evaluation element. For example, the original content of HE3 was “Implementing 
EHR helps your hospital to improve the capacity of clinical service within its location.” However, 
experts suggested that such a question needs to be modified as follow: (1) Implementing EHR helps 
your hospital to improve the competition of clinical service within its location. (2) Implementing EHR 
helps your hospital to enhance the capacity of patient care within its location. Accordingly, this study 
recalculated the values of S-CVI/Ave in the element of HE, OB, UU and US after those seven 
questions are removed from the evaluation element in Round II.   
First  round (n=23) Second round (n=19)  A B C D A B C D 
Important N % N % N % Mean % N % N % N % Mean % 
HE1 1 4.35 0 0.00 22 95.65 4.39 87.80 0 0.00 0 0.00 19 100.00 4.37 87.37 
HE2 3 13.04 6 26.09 14 60.87 3.61 72.20 1 5.26 4 21.05 14 73.68 3.89 77.89 
HE3 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
HE4 0 0.00 2 8.70 21 91.30 4.30 86.00 0 0.00 1 5.26 18 94.74 4.32 86.32 
OB1 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.16 83.16 
OB2 2 8.70 1 4.35 20 86.96 4.13 82.60 2 10.53 4 21.05 13 68.42 3.79 75.79 
OB3 2 8.70 4 17.39 17 73.91 3.78 75.60 0 0.00 2 10.53 17 89.47 4.32 86.32 
OB4 4 17.39 4 17.39 15 65.22 3.74 74.80 15 78.95 1 5.26 3 15.79 1.95 38.95 
OB5 1 4.35 2 8.70 20 86.96 4.43 88.60 0 0.00 1 5.26 18 94.74 4.42 88.42 
OB6 1 4.35 3 13.04 19 82.61 4.26 85.20 0 0.00 0 0.00 19 100.00 4.53 90.53 
OB7-1 1 4.35 2 8.70 20 86.96 4.22 84.40 0 0.00 1 5.26 18 94.74 4.42 88.42 
OB7-2 1 4.35 1 4.35 21 91.30 4.22 84.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
OB7-3 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.37 87.37 
OB8 1 4.35 0 0.00 22 95.65 4.30 86.00 0 0.00 0 0.00 19 100.00 4.63 92.63 
Sys_Q1 2 8.70 1 4.35 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.32 86.32 
Sys_Q2 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
Sys_Q3 0 0.00 1 4.35 22 95.65 3.78 75.60 0 0.00 1 5.26 18 94.74 4.37 87.37 
Sys_Q4 1 4.35 5 21.74 17 73.91 3.74 74.80 0 0.00 1 5.26 18 94.74 4.47 89.47 
Sys_Q5 0 0.00 0 0.00 23 100.00 4.43 88.60 0 0.00 1 5.26 18 94.74 4.58 91.58 
Sys_Q6 0 0.00 4 17.39 19 82.61 4.26 85.20 0 0.00 1 5.26 18 94.74 4.53 90.53 
Sys_Q7 0 0.00 0 0.00 23 100.00 4.22 84.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
Sys_Q8 1 4.35 0 0.00 22 95.65 4.22 84.40 0 0.00 0 0.00 19 100.00 4.63 92.63 
Sys_Q9 0 0.00 0 0.00 23 100.00 4.35 87.00 0 0.00 1 5.26 18 94.74 4.47 89.47 
MDQ1 1 4.35 1 4.35 21 91.30 4.48 89.60 1 5.26 0 0.00 18 94.74 4.47 89.47 
MDQ2 0 0.00 0 0.00 23 100.00 4.57 91.40 0 0.00 0 0.00 19 100.00 4.58 91.58 
MDQ3 0 0.00 1 4.35 22 95.65 4.57 91.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
MDQ4 0 0.00 2 8.70 21 91.30 4.57 91.40 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ5 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 0 0.00 19 100.00 4.42 88.42 
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MDQ6 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ7 1 4.35 1 4.35 21 91.30 4.30 86.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ8 0 0.00 1 4.35 22 95.65 4.57 91.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
MDQ9 0 0.00 0 0.00 23 100.00 4.48 89.60 0 0.00 1 5.26 18 94.74 4.63 92.63 
MDQ10 1 4.35 0 0.00 22 95.65 4.57 91.40 0 0.00 0 0.00 19 100.00 4.58 91.58 
Ser_Q1 0 0.00 2 8.70 21 91.30 4.43 88.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
Ser_Q2 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
Ser_Q3 3 13.04 0 0.00 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.37 87.37 
Ser_Q4 1 4.35 2 8.70 20 86.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.47 89.47 
Ser_Q5 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.53 90.53 
Ser_Q6 0 0.00 3 13.04 20 86.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
Ser_Q7 1 4.35 1 4.35 21 91.30 4.52 90.40 0 0.00 1 5.26 18 94.74 4.63 92.63 
Safe_Q1 0 0.00 1 4.35 22 95.65 4.7 94.00 0 0.00 1 5.26 18 94.74 4.63 92.63 
Safe_Q2 2 8.70 1 4.35 20 86.96 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q3 0 0.00 0 0.00 23 100.00 4.78 95.60 0 0.00 0 0.00 19 100.00 4.79 95.79 
Safe_Q4 1 4.35 2 8.70 20 86.96 4.52 90.40 0 0.00 1 5.26 18 94.74 4.68 93.68 
Safe_Q5 0 0.00 0 0.00 23 100.00 4.61 92.20 0 0.00 1 5.26 18 94.74 4.68 93.68 
Safe_Q6 1 4.35 0 0.00 22 95.65 4.61 92.20 0 0.00 1 5.26 18 94.74 4.74 94.74 
Safe_Q7 0 0.00 1 4.35 22 95.65 4.57 91.40 0 0.00 1 5.26 18 94.74 4.58 91.58 
Safe_Q8 0 0.00 2 8.70 21 91.30 4.48 89.60 0 0.00 0 0.00 19 100.00 4.74 94.74 
Safe_Q9 1 4.35 0 0.00 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
Safe_Q10 0 0.00 1 4.35 22 95.65 4.48 89.60 0 0.00 1 5.26 18 94.74 4.79 95.79 
Safe_Q11 1 4.35 2 8.70 20 86.96 4.17 83.40 0 0.00 1 5.26 18 94.74 4.68 93.68 
UU1-1 2 8.70 1 4.35 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.68 93.68 
UU1-2 2 8.70 2 8.70 19 82.61 4.26 85.20 0 0.00 0 0.00 19 100.00 4.53 90.53 
UU1-3 1 4.35 2 8.70 20 86.96 4.26 85.20 0 0.00 0 0.00 19 100.00 4.53 90.53 
UU1-4 3 13.04 1 4.35 19 82.61 3.96 79.20 0 0.00 0 0.00 19 100.00 4.37 87.37 
UU2 2 8.70 4 17.39 17 73.91 3.96 79.20 0 0.00 2 10.53 17 89.47 4.37 87.37 
UU3 1 4.35 0 0.00 22 95.65 4.30 86.00 0 0.00 2 10.53 17 89.47 4.26 85.26 
UU4 3 13.04 1 4.35 19 82.61 4.13 82.60 3 15.79 3 15.79 13 68.42 3.89 77.89 
UU5 4 17.39 0 0.00 19 82.61 3.74 74.80 4 21.05 1 5.26 14 73.68 3.79 75.79 
US1 1 4.35 1 4.35 21 91.30 4.26 85.20 0 0.00 1 5.26 18 94.74 4.37 87.37 
US2 4 17.39 2 8.70 17 73.91 3.83 76.60 4 21.05 1 5.26 14 73.68 3.89 77.89 
US3 1 4.35 1 4.35 21 91.30 4.30 86.00 0 0.00 0 0.00 19 100.00 4.42 88.42 
US4-1 4 17.39 4 17.39 15 65.22 3.52 70.40 8 42.11 1 5.26 10 52.63 3.11 62.11 
US4-2 1 4.35 3 13.04 19 82.61 4.17 83.40 0 0.00 1 5.26 18 94.74 4.37 87.37 
US4-3 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 0 0.00 19 100.00 4.42 88.42 
US4-4 1 4.35 1 4.35 21 91.30 4.35 87.00 0 0.00 1 5.26 18 94.74 4.21 84.21 
US5-1 0 0.00 0 0.00 23 100.00 4.39 87.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
US5-2 2 8.70 2 8.70 19 82.61 4.17 83.40 0 0.00 1 5.26 18 94.74 4.37 87.37 
US5-3 1 4.35 0 0.00 22 95.65 4.26 85.20 0 0.00 1 5.26 18 94.74 4.42 88.42 
ONB1 0 0.00 2 8.70 21 91.30 4.48 89.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
ONB2 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.32 86.32 
ONB3 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
ONB4 0 0.00 2 8.70 21 91.30 4.30 86.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
ONB5 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.32 86.32 
ONB6 0 0.00 1 4.35 22 95.65 4.48 89.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
ONB7 2 8.70 2 8.70 19 82.61 4.09 81.80 0 0.00 1 5.26 18 94.74 4.42 88.42 
Feasibility 
HE1 1 4.35 2 8.70 20 86.96 3.91 78.20 0 0.00 1 5.26 18 94.74 4.26 85.26 
HE2 3 13.04 4 17.39 16 69.57 3.74 74.80 1 5.26 4 21.05 14 73.68 3.89 77.89 
HE3 0 0.00 1 4.35 22 95.65 4.30 86.00 0 0.00 1 5.26 18 94.74 4.26 85.26 
HE4 1 4.35 4 17.39 18 78.26 3.96 79.20 0 0.00 1 5.26 18 94.74 4.32 86.32 
OB1 1 4.35 1 4.35 21 91.30 4.04 80.80 0 0.00 1 5.26 18 94.74 4.26 85.26 
OB2 3 13.04 1 4.35 19 82.61 4.25 85.00 3 15.79 2 10.53 14 73.68 3.79 75.79 
OB3 4 17.39 3 13.04 16 69.57 3.65 73.00 0 0.00 2 10.53 17 89.47 4.21 84.21 
OB4 6 26.09 4 17.39 13 56.52 3.43 68.60 15 78.95 1 5.26 3 15.79 2.00 40.00 
OB5 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.37 87.37 
OB6 2 8.70 5 21.74 16 69.57 3.96 79.20 0 0.00 0 0.00 19 100.00 4.37 87.37 
OB7-1 1 4.35 1 4.35 21 91.30 4.26 85.20 0 0.00 1 5.26 18 94.74 4.47 89.47 
OB7-2 2 8.70 0 0.00 21 91.30 4.22 84.40 1 5.26 3 15.79 15 78.95 4.16 83.16 
OB7-3 3 13.04 0 0.00 20 86.96 3.96 79.20 0 0.00 1 5.26 18 94.74 4.42 88.42 
OB8 0 0.00 2 8.70 21 91.30 4.04 80.80 0 0.00 0 0.00 19 100.00 4.53 90.53 
Sys_Q1 2 8.70 2 8.70 19 82.61 4.04 80.80 0 0.00 1 5.26 18 94.74 4.26 85.26 
Sys_Q2 1 4.35 5 21.74 17 73.91 4.00 80.00 0 0.00 0 0.00 19 100.00 4.37 87.37 
Sys_Q3 0 0.00 1 4.35 22 95.65 4.22 84.40 0 0.00 1 5.26 18 94.74 4.32 86.32 
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Sys_Q4 1 4.35 3 13.04 19 82.61 4.04 80.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
Sys_Q5 1 4.35 1 4.35 21 91.03 4.39 87.80 0 0.00 1 5.26 18 94.74 4.53 90.53 
Sys_Q6 0 0.00 3 13.04 20 86.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.37 87.37 
Sys_Q7 0 0.00 1 4.35 22 95.65 4.39 87.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
Sys_Q8 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
Sys_Q9 0 0.00 0 0.00 23 100.00 4.39 87.80 0 0.00 1 5.26 18 94.74 4.42 88.42 
MDQ1 1 4.35 0 0.00 22 95.65 4.52 90.40 1 5.26 0 0.00 18 94.74 4.47 89.47 
MDQ2 0 0.00 1 4.35 22 95.65 4.52 90.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
MDQ3 0 0.00 1 4.35 22 95.65 4.52 90.40 0 0.00 1 5.26 18 94.74 4.53 90.53 
MDQ4 0 0.00 1 4.35 22 95.65 4.65 93.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ5 0 0.00 2 8.70 21 91.30 4.26 85.20 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ6 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.42 88.42 
MDQ7 0 0.00 1 4.35 22 95.65 4.30 86.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ8 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
MDQ9 0 0.00 0 0.00 23 100.00 4.57 91.40 0 0.00 0 0.00 19 100.00 4.58 91.58 
MDQ10 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 0 0.00 19 100.00 4.47 89.47 
Ser_Q1 3 13.04 2 8.70 18 78.26 3.96 79.20 0 0.00 1 5.26 18 94.74 4.32 86.32 
Ser_Q2 4 17.39 1 4.35 18 78.26 3.91 78.20 0 0.00 1 5.26 18 94.74 4.32 86.32 
Ser_Q3 2 8.70 2 8.70 19 82.61 4.17 83.40 1 5.26 0 0.00 18 94.74 4.21 84.21 
Ser_Q4 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 0 0.00 19 100.00 4.37 87.37 
Ser_Q5 1 4.35 3 13.04 19 82.61 4.00 80.00 0 0.00 1 5.26 18 94.74 4.47 89.47 
Ser_Q6 1 4.35 0 0.00 22 95.65 4.30 86.00 0 0.00 0 0.00 19 100.00 4.47 89.47 
Ser_Q7 3 13.04 2 8.70 18 78.26 3.96 79.20 0 0.00 0 0.00 19 100.00 4.53 90.53 
Safe_Q1 0 0.00 2 8.70 21 91.30 4.61 92.20 0 0.00 1 5.26 18 94.74 4.58 91.58 
Safe_Q2 2 8.70 1 4.35 20 86.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
Safe_Q3 0 0.00 0 0.00 23 100.00 4.70 94.00 0 0.00 1 5.26 18 94.74 4.63 92.63 
Safe_Q4 1 4.35 1 4.35 21 91.30 4.43 88.60 0 0.00 0 0.00 19 100.00 4.47 89.47 
Safe_Q5 0 0.00 0 0.00 23 100.00 4.65 93.00 0 0.00 1 5.26 18 94.74 4.58 91.58 
Safe_Q6 1 4.35 0 0.00 22 95.65 4.52 90.40 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q7 0 0.00 2 8.70 21 91.30 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q8 0 0.00 1 4.35 22 95.65 4.52 90.40 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q9 1 4.35 1 4.35 21 91.30 4.30 86.00 0 0.00 0 0.00 19 100.00 4.37 87.37 
Safe_Q10 0 0.00 0 0.00 23 100.00 4.48 89.60 0 0.00 0 0.00 19 100.00 4.63 92.63 
Safe_Q11 1 4.35 1 4.35 21 91.30 4.22 84.40 0 0.00 0 0.00 19 100.00 4.79 95.79 
UU1-1 1 4.35 1 4.35 21 91.30 4.09 81.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
UU1-2 1 4.35 2 8.70 20 86.96 4.22 84.40 0 0.00 0 0.00 19 100.00 4.37 87.37 
UU1-3 0 0.00 2 8.70 21 91.30 4.26 85.20 0 0.00 0 0.00 19 100.00 4.32 86.32 
UU1-4 2 8.70 1 4.35 20 86.96 4.04 80.80 0 0.00 0 0.00 19 100.00 4.37 87.37 
UU2 1 4.35 1 4.35 21 91.30 4.13 82.60 0 0.00 2 10.53 17 89.47 4.32 86.32 
UU3 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 2 10.53 17 89.47 4.21 84.21 
UU4 4 17.39 0 0.00 19 82.61 3.91 78.20 4 21.05 1 5.26 14 73.68 3.74 74.74 
UU5 2 8.70 0 0.00 21 91.30 4.00 80.00 4 21.05 1 5.26 14 73.68 3.74 74.74 
US1 1 4.35 0 0.00 22 95.65 4.22 84.40 0 0.00 0 0.00 19 100.00 4.58 91.58 
US2 4 17.39 2 8.70 17 73.91 3.83 76.60 3 15.79 2 10.53 14 73.68 3.84 76.84 
US3 1 4.35 0 0.00 22 0.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
US4-1 3 13.04 4 17.39 16 69.57 3.61 72.20 11 57.89 1 5.26 7 36.84 2.68 53.68 
US4-2 1 4.35 3 13.04 19 82.61 4.17 83.40 1 5.26 1 5.26 17 89.47 4.16 83.16 
US4-3 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.37 87.37 
US4-4 1 4.35 2 8.70 20 86.96 4.26 85.20 0 0.00 1 5.26 18 94.74 4.21 84.21 
US5-1 0 0.00 1 4.35 22 95.65 4.35 87.00 0 0.00 1 5.26 18 94.74 4.47 89.47 
US5-2 2 8.70 1 4.35 20 86.96 4.26 85.20 0 0.00 1 5.26 18 94.74 4.37 87.37 
US5-3 1 4.35 0 0 22 95.65 4.35 87.00 0 0.00 0 0.00 19 100.0 4.58 91.58 
ONB1 2 8.70 2 8.70 19 82.61 3.96 79.20 0 0.00 3 15.79 16 84.21 4.26 85.20 
ONB2 0 0.00 1 4.35 22 95.65 4.30 86.00 0 0.00 0 0.00 19 100.00 4.47 89.40 
ONB3 1 4.35 2 8.70 20 86.96 4.09 81.80 0 0.00 0 0.00 19 100.00 4.53 90.60 
ONB4 0 0.00 3 13.04 20 86.96 4.22 84.40 0 0.00 1 5.26 18 94.74 4.32 86.40 
ONB5 2 8.70 0 0.00 21 91.30 3.96 79.20 0 0.00 3 15.79 16 84.21 4.26 85.20 
ONB6 1 4.35 0 0.00 22 95.65 4.30 86.00 0 0.00 1 5.26 18 94.74 4.47 89.40 
ONB7 2 8.70 1 4.35 20 86.96 4.17 83.40 0 0.00 2 10.53 17 89.47 4.37 87.40 
Confidence 
HE1 1 4.35 4 17.39 18 78.26 3.87 77.40 0 0.00 1 5.26 18 94.74 4.16 83.16 
HE2 5 21.74 5 21.74 13 56.52 3.39 67.80 1 5.26 5 26.32 13 68.42 3.84 76.84 
HE3 0 0.00 2 0.09 21 91.30 4.17 83.40 0 0.00 1 5.26 18 94.74 4.26 85.26 
HE4 1 4.35 3 13.04 19 82.61 3.91 78.20 0 0.00 1 5.26 18 94.74 4.37 87.37 
OB1 2 8.70 2 8.70 19 82.61 3.91 78.20 0 0.00 2 10.53 17 89.47 4.21 84.21 
OB2 2 8.70 3 13.04 18 78.26 4.13 82.60 2 10.53 3 15.79 14 73.68 3.84 76.84 
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OB3 3 13.04 6 26.09 14 60.87 3.61 72.20 0 0.00 3 15.79 16 84.21 4.11 82.11 
OB4 7 30.43 4 17.39 12 52.17 3.26 65.20 12 63.16 1 5.26 6 31.58 2.42 48.42 
OB5 1 4.35 2 8.70 20 86.96 4.13 82.60 0 0.00 2 10.53 17 89.47 4.21 84.21 
OB6 2 8.70 5 21.74 16 69.57 3.87 77.40 0 0.00 1 5.26 18 94.74 4.32 86.32 
OB7-1 1 4.35  0 0.00 22 95.65 4.22 84.40 0 0.00 2 10.53 17 89.47 4.26 85.26 
OB7-2 2 8.70 12 52.17 9 39.13 4.3 86.00 0 0.00 1 5.26 18 94.74 4.42 88.42 
OB7-3 1 4.35 3 13.04 19 82.61 3.87 77.40 0 0.00 1 5.26 18 94.74 4.42 88.42 
OB8 1 4.35 3 13.04 19 82.61 4.04 80.80 0 0.00 0 0.00 19 100.00 4.47 89.47 
Sys_Q1 3 13.04 2 8.70 18 78.26 3.78 75.60 0 0.00 1 5.26 18 94.74 4.26 85.26 
Sys_Q2 1 4.35 5 21.74 17 73.91 3.91 78.20 0 0.00 1 5.26 18 94.74 4.37 87.37 
Sys_Q3 1 4.35 2 8.70 20 86.96 4.00 80.00 0 0.00 1 5.26 18 94.74 4.21 84.21 
Sys_Q4 1 4.35 3 13.04 19 82.61 3.96 79.20 0 0.00 1 5.26 18 94.74 4.26 85.26 
Sys_Q5 1 4.35 3 13.04 19 82.61 4.22 84.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
Sys_Q6 0 0.00 5 21.74 18 78.26 4.22 84.40 0 0.00 2 10.53 17 89.47 4.26 85.26 
Sys_Q7 0 0.00 3 13.04 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.32 86.32 
Sys_Q8 1 4.35 2 8.70 20 86.96 4.26 85.20 0 0.00 0 0.00 19 100.00 4.37 87.37 
Sys_Q9 0 0.00 4 17.39 19 82.61 4.00 80.00 0 0.00 1 5.26 18 94.74 4.26 85.26 
MDQ1 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.37 87.37 
MDQ2 0 0.00 2 8.70 21 91.30 4.39 87.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
MDQ3 0 0.00 1 4.35 22 95.65 4.39 87.80 0 0.00 1 5.26 18 94.74 4.47 89.47 
MDQ4 1 4.35 3 13.04 19 82.61 4.13 82.60 0 0.00 0 0.00 19 100.00 4.37 87.37 
MDQ5 0 0.00 3 13.04 20 86.96 4.13 82.60 0 0.00 1 5.26 18 94.74 4.32 86.32 
MDQ6 0 0.00 2 8.70 21 91.30 4.17 83.40 0 0.00 1 5.26 18 94.74 4.32 86.32 
MDQ7 2 8.70 1 4.35 20 86.96 4.04 80.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
MDQ8 0 0.00  0.00 23 100.00 4.39 87.80 0 0.00 1 5.26 18 94.74 4.53 90.53 
MDQ9 0 0.00  0.00 23 100.00 4.48 89.60 0 0.00 0 0.00 19 100.00 4.47 89.47 
MDQ10 0 0.00 1 4.35 22 95.65 4.52 90.40 0 0.00 0 0.00 19 100.00 4.53 90.53 
Ser_Q1 1 4.35 4 17.39 18 78.26 4.04 80.80 0 0.00 1 5.26 18 94.74 4.32 86.32 
Ser_Q2 1 4.35 4 17.39 18 78.26 4.04 80.80 0 0.00 1 5.26 18 94.74 4.26 85.26 
Ser_Q3 3 13.04 4 17.39 16 69.57 3.70 74.00 1 5.26% 0 0.00 18 94.74 4.16 83.16 
Ser_Q4 1 4.35 3 13.04 19 82.61 4.09 81.80 0 0.00 1 5.26 18 94.74 4.32 86.32 
Ser_Q5 0 0.00 1 4.35 22 95.65 4.22 84.40 0 0.00 1 5.26 18 94.74 4.53 90.53 
Ser_Q6 0 0.00 5 21.74 18 78.26 4.17 83.40 0 0.00 1 5.26 18 94.74 4.42 88.42 
Ser_Q7 1 4.35 3 13.04 19 82.61 4.09 81.80 0 0.00 1 5.26 18 94.74 4.37 87.37 
Safe_Q1 0 0.00 2 8.70 21 91.30 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q2 1 4.35 2 8.70 20 86.96 4.35 87.00 0 0.00 1 5.26 18 94.74 4.37 87.37 
Safe_Q3 0 0.00 1 4.35 22 95.65 4.61 92.20 0 0.00 0 0.00 19 100.00 4.53 90.53 
Safe_Q4 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
Safe_Q5 0 0.00 1 4.35 22 95.65 4.43 88.60 0 0.00 1 5.26 18 94.74 4.58 91.58 
Safe_Q6 0 0.00 1 4.35 22 95.65 4.48 89.60 0 0.00 1 5.26 18 94.74 4.58 91.58 
Safe_Q7 1 4.35 2 8.70 20 86.96 4.26 85.20 0 0.00 1 5.26 18 94.74 4.42 88.42 
Safe_Q8 1 4.35 1 4.35 21 91.30 4.22 84.40 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q9 1 4.35 3 13.04 19 82.61 4.13 82.60 0 0.00 1 5.26 18 94.74 4.26 85.26 
Safe_Q10 0 0.00  0.00 23 100.00 4.43 88.60 0 0.00 1 5.26 18 94.74 4.53 90.53 
Safe_Q11 0 0.00 1 4.35 22 95.65 4.26 85.20 0 0.00 0 0.00 19 100.00 4.63 92.63 
UU1-1 2 8.70 2 8.70 19 82.61 3.87 79.20 0 0.00 1 5.26 18 94.74 4.37 87.37 
UU1-2 1 4.35 2 8.70 20 86.96 4.09 81.80 0 0.00 1 5.26 18 94.74 4.21 84.21 
UU1-3 1 4.35 3 13.04 19 82.61 4.04 80.80 0 0.00 1 5.26 18 94.74 4.21 84.21 
UU1-4 1 4.35 1 4.35 21 91.30 4.22 84.40 0 0.00 1 5.26 18 94.74 4.26 85.26 
UU2 0 0.00 3 13.04 20 86.96 4.13 82.60 0 0.00 3 15.79 16 84.21 4.05 81.05 
UU3 1 4.35 1 4.35 21 91.30 4.13 82.60 0 0.00 2 10.53 17 89.47 4.26 85.26 
UU4 1 4.35 1 4.35 21 91.30 4.22 84.40 3 15.79 2 10.53 14 73.68 3.89 77.89 
UU5 2 8.70 2 8.70 19 82.61 3.87 77.40 2 10.53 3 15.79 14 73.68 3.84 76.84 
US1 1 4.35 1 4.35 21 91.30 4.17 83.40 2 10.53 1 5.26 16 84.21 4.00 80.00 
US2 3 13.04 2 8.70 18 78.26 3.83 76.60 0 0.00 6 31.58 13 68.42 4.00 80.00 
US3 0 0.00 1 4.35 22 95.65 4.39 87.80 1 5.26 2 10.53 16 84.21 4.05 81.05 
US4-1 1 4.35 5 21.74 17 73.91 3.83 76.60 11 57.89 1 5.26 7 36.84 2.68 53.68 
US4-2 1 4.35 3 13.04 19 82.61 4.09 81.80 0 0.00 0 0.00 19 100.00 4.53 90.53 
US4-3 0 0.00 2 8.70 21 91.30 4.30 86.00 1 5.26 2 10.53 16 84.21 4.11 82.11 
US4-4 1 4.35 3 13.04 19 82.61 4.09 81.80 0 0.00 1 5.26 18 94.74 4.32 86.32 
US5-1 0 0.00 2 8.70 21 91.30 4.17 83.40 0 0.00 1 5.26 18 94.74 4.26 85.26 
US5-2 0 0.00 2 8.70 21 91.30 4.17 83.40 0 0.00 1 5.26 18 94.74 4.47 89.47 
US5-3 1 4.35 2 8.70 20 86.96 4.04 80.80 0 0.00 0 0.00 19 100.00 4.53 90.53 
ONB1 1 4.35 2 8.70 20 86.96 4.04 80.80 1 5.26 0 0.00 18 94.74 4.37 87.37 
ONB2 0 0.00  0.00 23 100 4.26 85.20 0 0.00 0 0.00 19 100.00 4.47 89.47 
ONB3 0 0.00 3 13.04 20 86.96 4.13 82.60 0 0.00 0 0.00 19 100.00 4.53 90.53 
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ONB4 1 4.35 3 13.04 19 82.61 3.96 79.20 0 0.00 1 5.26 18 94.74 4.32 86.32 
ONB5 3 13.04 1 4.35 19 82.61 3.78 75.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
ONB6 1 4.35 3 13.04 19 82.61 4.13 82.60 0 0.00 1 5.26 18 94.74 4.47 89.47 
ONB7 1 4.35 3 13.04 19 82.61 4.09 81.80 0 0.00 1 5.26 18 94.74 4.42 88.42 
A: Items rated 1 or 2; B: Items rated 3; C: Items rated 4 or 5; D: Mean of Items rated by all experts 
Table 2.  Results of I-CVI within the modified Delphi method 
According to the results of S-CVI in Table 3, some questions of the original elements of HE, OB, UU 
and US needed to be removed from the proposed instrument. Therefore, after those unsuitable 
questions were removed from the instrument, the values of S-CVI/Ave are greater than 90% (cut-off 
point); in other words, the elements of HE, OB, UU and US achieve high content validity and such 
instrument could be used to evaluate end-users’ opinion of using EHRs.  
  HE OB Sys_Q 
    A B C A B C A B C 
N 79 76 71 96 190 168 189 185 170 First round 
(n=23) % 85.87 82.61 77.17 85.22 82.61 73.04 91.3 89.37 82.13 
N 69 68 67 161 159 160 163 164 162 Second round 
(n=19) % 90.79 89.47 88.16 84.74 83.68 84.21 95.32 95.91 94.74 
Revised  96.49 94.74 94.74 95.40 94.01 92.11    
  MDQ Ser_Q Safe_Q 
  A B C A B C A B C 
N 219 220 213 146 136 130 237 238 234 First round 
(n=23) % 95.22 95.65 92.61 90.68 84.47 80.75 93.68 94 .07 92.49 
N 186 185 183 126 129 126 200 202 200 Second round 
(n=19) % 97.89 97.37 96.32 96.74 96.99 96.74 95.69 96.65 95.69 
Revised           
  UU US ONB 
  A B C A B C A B C 
N 155 165 160 200 202 199 145 144 139 First round 
(n=23) % 84.24 89.67 86.96 86.96 87.83 86.52 90.06 89.44 86.34 
N 136 138 133 170 166 160 127 123 128 Second round 
(n=19) % 89.47 90.79 87.5 89.47 87.37 84.21 95.49 92.48 96.24 
Revised  95.61 95.61 92.11 96.06 95.40 92.11    
A: Important; B: Feasibility; C: Confidence 
Table 3.  Results of S-CVI within modified Delphi method 
5 DISCUSSION AND CONCLUSION 
As it aforementioned that there are four features of the Delphi method: anonymity (nameless), 
iteration (at least twice), controlled feedback (removed inappropriate questions), and 
aggregation of group answers (converting individual viewpoint into group consensus). The 
modified Delphi method enables this study to provide a prepared questionnaire for Delphi 
group to reflect on the specific aim of the instrument, and to anonymous write their 
comments on each question. The process of this method will generate both quantitative 
(I-CVI and S-CVI) and qualitative results for confirming the content validity of each question: 
(1) a quantitative approach helps to remove inappropriate questions; (2) a qualitative 
approach assists in providing sufficient evidence for explaining the reason for eliminating 
questions from the proposed instrument. In short, a qualitative approach to the Delphi method 
not only helps to explain the reasons for removing questions, but also assists in revising the 
content, wording and syntax of each question for targeting a specific research theme among a 
panel of experts. By the way of two-interactive Delphi method, accordingly, the overall process of 
both I-CVI and S-CVI helped to ensure the content validity of each question and element. Each 
question and element in this instrument contains high content validity. Consequently, the number of 
questions was reduced from 76 to 74, with a free-text added to measure end-users’ opinion of using 
EHRs in Taiwan.  
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Table 3 indicates that questions in the aspect of Technological and Net Benefits were not changed; 
however, there is a minor modification in the aspects of Organizational and Human. Significantly, all 
experts in the Delphi group were executive managers in hospitals. The results of using the 
two-interactive Delphi method indicate that questions in System Quality, Medical Data Quality, 
Service Quality, Safety quality and Organizational Net Benefits are appropriate for supporting 
decision-making; questions that needed to be removed were not relevant to the underlying construct. 
These responses from a panel of experts enabled the conversion of individual subjective viewpoints 
into a group objective consensus. This result indicates that the selections of experts as the participants 
of the Delphi group are important, because they are related to the specific research theme of this study. 
Previous research has recommended the Delphi as being an appropriate method in identifying 
the content validity of an instrument (Takemura, Liu et al. 2006; Rushton & Lindsay 2008). 
Accordingly, a modified Delphi method and the method of both investigators and data were 
used in this study to develop a suitable instrument for measuring Taiwanese EHRs success. In 
order to clarify the main function of modified Delphi method and to explain the method of 
computing I-CVI/S-CVI for confirming the content validity of the proposed instrument, this 
study also explained its three main elements: (1) function and intention of the Delphi group; 
(2) selecting appropriate participants as the Delphi group; (3) methods of identifying content 
validity index (CVI): the cut-off point of I-CVI being 78% (90% for S-CVI).  
Results of using the two-interactive Delphi method were discussed based on both quantitative 
and qualitative research approaches. Twenty-three of thirty experts (76.67%) responded to 
Round I, and nineteen of twenty-three (82.60%) responded to Round II, the degree of 
consensus being stable among experts in Round II. The overall results of the two-iterative 
Delphi method indicate that seven questions (HE2, OB2, OB4, UU4, UU5, US2 and US4-1) 
need to be removed from the proposed instrument, and that five questions (HE3, HE4, UU2, 
UU3 and US3) need to be modified to be more relevant to the proposed evaluation element. 
Finally, the number of questions was reduced from 76 to 74, with a free-text added to 
measure end-users’ opinion of using EHR system in Taiwan (Table 4). 
Delphi Method Evaluation Elements Original Revised Removed Modified 
Organizational Aspect 
Healthcare Environment * 4 5 HE2 HE3, HE4 
Organization Behaviours * 10 8 OB2, OB4  
Technological Aspect 
System Quality 9 9 -- -- 
Medical Data Quality 10 10 -- -- 
Service Quality 7 7 -- -- 
Safety Quality 11 11 -- -- 
Human Aspect 
User Usage * 8 8 UU4, UU5 UU2, UU3 
User Satisfaction * 10 9 US2, US4-1 US3 
Net Benefits Aspect 
Organizational Net Benefits 7 7 -- -- 
Total 76 74  
* questions have be removed or revised; -- there is no change 
Table 4: the development of instrument in each version (Unit: questions) 
A “good” research instrument needs to demonstrate construct validity and reliability with 
larger samples for ensuring both “reliability” and “validity” (Ammenwerth, Kaiser et al. 
2003). However, the first phase for providing a good instrument is to confirm its content 
validity. For performing the Delphi method, therefore, selecting “experts” as the participants 
of the Delphi group are very important because they need to understand and have experiences 
which are related to the specific research theme of performing such method. The results of 
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this study identify that the modified Delphi method is indeed a useful technique to combine 
both quantitative (can be processed statistically) and qualitative (anonymous written 
explanations in conjunction with controlled feedback) research approaches in designing a 
suitable instrument. A qualitative approach provided a reference to modify the wording and/or 
syntax of questions for implementing such instrument in real medical environment. In short, based 
on results of this study, an appropriate instrument was provided to measure end-users’ 
opinions of using EHR systems in Taiwan. 
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